Quest Diagnostics planned launch for coronavirus disease 2019 (COVID-19) test
On Mar. 5, 2020, Quest Diagnostics announced it will launch a coronavirus (COVID-19) test service. The new test…
Vir Biotec and and Alnylam expanded collaboration to advance RNAi therapeutics for reatment of Coronavirus Infection
On Mar. 4, 2020, Vir Biotech and Alnylam Pharmaceuticals announced an expansion of their existing collaboration to include…
Moderna completed enrollment of Cytomegalovirus vaccine (mRNA-1647) phase 2 study
On Mar. 3, 2020, Moderna announced that enrollment was complete for all three dose cohorts of the Phase…
Moderna shipped mRNA vaccine against novel Coronavirus (mRNA-1273) for phase 1 study
On Feb. 24, 2020, Moderna announced it had released the first batch of mRNA-1273, the Company’s vaccine against…
Moderna announced funding award from CEPI to accelerate development of mRNA vaccine against novel Coronavirus
On Jan. 23, 2020, Moderna announced a new collaboration to develop an mRNA vaccine against the novel coronavirus…
NIH grant awarded to Georgia Tech researchers to develop mRNA-based drug to correct hematopoietic stem cells
On Oct. 1, 2019, the National Institutes of Health (NIH) awarded a $3.5 million grant to Georgia Institute…
Eleventh U.S. CRISPR-Cas9 Patent Awarded to University of California, U Vienna, Charpentier
On Aug. 20, 2019, the eleventh U.S. CRISPR-Cas9 patent was awarded to University of California, the University of…
Yale professor Joan Steitz awarded the 2018 Lasker~Koshland Special Achievement Award in Medical Science
On Sept. 11, 2018, Joan Steitz, Sterling Professor of Molecular Biophysics and Biochemistry at Yale, received the 2018ï¾ …
UCSD researchers discovered that a type of DNA-repairing enzyme is neutralized by DNA lesions caused by exposure to ultraviolet light
On Aug. 22, 2018, University of California, San Diego (UCSD) researchers with colleagues in Spain and Finland, described…
Pacific Northwest Diabetes Research Institute received a $2 million grant for RNA research
On Aug. 6, 2013, Pacific Northwest Diabetes Research Institute (PNDRI) received a $2 million National Institutes of Health…
draft genome and transcriptome of Cannabis sativa published
On Oct. 20, 2011, researchers announced they had sequenced genomic DNA and RNA from the marijuana strain Purple…
The Belly Button Biodiversity project was launched
On Jan. 3, 2011, the Belly Button Biodiversity project was launched to investigate the microbes inhabiting our navels…
Marina Biotech acquired Cequent Pharmaceuticals for $44 million
On Jul. 22, 2010, MDRNA announced that MDRNA shareholders approved the issuance of shares of MDRNA common stock…
Phase III results for first HIV/AIDS (Aidsvax) vaccine reported
On Sept. 24, 2009, the second Phase III HIV-1 vaccine trial, also known as RV144, that began in…
James Carrington, a professor of botany at Oregon State University was elected to the National Academy of Sciences
On Feb. 25, 2008, Oregon State University’s James Carrington, a professor of botany and plant pathology and a…
The CDC received FDA approval for a highly sensitive influenza PCR assay
In 2008, the U.S. Centers for Disease Control and Prevention (CDC) received U.S. Food and Drug Administration (FDA)…
Integrated DNA Technologies acquired Belgian manufacturer and established European operating base in Leuven, Belgium
On Sept. 18, 2006, Integrated DNA Technologies (IDT) announced the acquisition of RNA-TEC, based in Leuven, Belgium. The…
Andrew Fire was awarded Nobel Prize in Physiology or Medicine
In 2006, Andrew Fire of Stanford Univeristy School of Medicine was awarded the 2006 Nobel Prize in Physiology…
The genome of the 1918 H1N1 pandemic influenza virus was sequenced
On Oct. 7, 2005, Jeffery Taubenberger, AH Reid, AE Krafft, Karen Bijwaard and Thomas Fanning published a report…
Stanford researchers became the first to use RNAi to switch off genes in mice
In 2002, Stanford researchers became the first to use RNAi to switch off genes in mice.
Stanford researchers solved the structure of the RNA polymerase protein
In 2000, Stanford researchers solved the structure of the RNA polymerase protein, a pivotal molecule that copies genes…
Ribozyme Pharmaceuticals announced IPO
On Apr. 12, 1996, Ribozyme Pharmaceuticals announced an initial public offering of 2,000,000 shares of its Common Stock…
Amgen acquired Boulder-based Synergen facility
In 1994, Amgen announced it had acquired Boulder-based Synergen for a $239.6-million or $9.25 per share. Synergen was…
Co-discovery of microRNAs
In 1993, Harvard Medical School Genetics researcher Gary Ruvkun co-discovered small regulatory RNAs (microRNAs), which led to RNA…
Drs. Joan and Ron Conaway at the OMRF discovered Elongin a genetic transcription factor
In 1993, Drs. Joan and Ron Conaway from the Oklahoma Medical Research Foundation (OMRF) discovered Elongin A (EloA)…
Thomas R Cech was awarded Nobel Laureate in Chemistry
In 1989, Thomas Cech from the University of Colorado in Boulder was awarded the 1989 Nobel Prize for…
Montreal-born Sidney Altman awarded share of the Nobel Prize in Chemistry “for their discovery of catalytic properties of RNA”
In 1989, Montreal-born Sidney Altman won a share of the Nobel Prize in Chemistry “for their discovery of…
The human p53 gene was cloned
On Dec. 20, 1984, a team of scientists announced that a cDNA clone for human p53 cellular tumor…
Discovery that treatment with human recombinant interferon gamma blocks the growth of T. gondii published
On Feb. 8, 1984, Elmer R. Pfefferkorn published his discovery that treatment of human fibroblasts with human recombinant…
Biotechnology | Diagnostics | Disease | FDA | Life Science News | Non-Profit Research | Therapeutics | Veterinary
University of Washington scientists created first “transgenic mouse”
In 1982, Richard D. Palmiter at the University of Washington scientists created first “transgenic mouse” in collaboration with…